Yan Yu

3.5k total citations · 2 hit papers
54 papers, 2.1k citations indexed

About

Yan Yu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yan Yu has authored 54 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 20 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Yan Yu's work include Cancer Immunotherapy and Biomarkers (12 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yan Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Yan Yu collaborates with scholars based in China, United States and Australia. Yan Yu's co-authors include Yang Zhou, Weitong Gao, Xueqian Wang, Yuqin Wang, Jingyan Cao, Ting Sun, Liang Ming, Yangxia Wang, Lin Jiao and Jin Shi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Yan Yu

51 papers receiving 2.1k citations

Hit Papers

Autophagy, ferroptosis, pyroptosis, and necroptosis in tu... 2021 2026 2022 2024 2022 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
    2022 690 citations Weitong Gao, Yuqin Wang et al. Signal Transduction and Targeted Therapy profile →
  2. Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
    2021 246 citations Shun Lü, Jun Zhao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Yu China 19 916 909 656 548 448 54 2.1k
Renea A. Taylor Australia 30 950 1.0× 768 0.8× 1.1k 1.7× 503 0.9× 292 0.7× 95 2.5k
Jian‐An Huang China 26 1.1k 1.2× 1.3k 1.5× 640 1.0× 687 1.3× 776 1.7× 87 2.7k
Hiromitsu Mimata Japan 27 1.1k 1.2× 663 0.7× 647 1.0× 632 1.2× 445 1.0× 181 2.9k
Fei Wu China 23 1.1k 1.2× 815 0.9× 487 0.7× 343 0.6× 433 1.0× 106 2.2k
Wenjie Zhu China 28 1.1k 1.2× 625 0.7× 315 0.5× 952 1.7× 392 0.9× 101 2.3k
Josefa Castillo Spain 20 946 1.0× 683 0.8× 331 0.5× 512 0.9× 283 0.6× 55 2.1k
Soumitro Pal United States 26 1.3k 1.4× 646 0.7× 277 0.4× 473 0.9× 493 1.1× 53 2.4k
Wei-Chao Chang Taiwan 20 1.4k 1.5× 648 0.7× 529 0.8× 734 1.3× 465 1.0× 33 2.3k
Federica Papaccio Italy 21 1.0k 1.1× 909 1.0× 293 0.4× 594 1.1× 185 0.4× 42 2.0k

Countries citing papers authored by Yan Yu

Since Specialization
Citations

This map shows the geographic impact of Yan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Yu more than expected).

Fields of papers citing papers by Yan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Yu. The network helps show where Yan Yu may publish in the future.

Co-authorship network of co-authors of Yan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Yu. A scholar is included among the top collaborators of Yan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Yu. Yan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ren, Haoyu, Yuqing Wang, Qingfeng Li, et al.. (2025). Comparison of adverse events between intensity-modulated radiation therapy and tomotherapy for early stage breast cancer: a retrospective cohort study. Frontiers in Oncology. 15. 1654609–1654609.
2.
Qin, Shukui, Ying Cheng, Qiming Wang, et al.. (2024). Preliminary results from a phase I expansion study of ZG005, a bispecific antibody targeting TIGIT and PD-1, as monotherapy in patients with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2611–2611.
3.
4.
Wang, Juan, Jun Zhao, Jia Zhong, et al.. (2023). 653O Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors. Annals of Oncology. 34. S459–S459. 17 indexed citations
5.
Fan, Yun, Yao Zhao, Dabing Huang, et al.. (2023). OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study. Journal of Thoracic Oncology. 18(11). S46–S46. 14 indexed citations
6.
7.
Zhang, Qilei, Yunhao Wu, Yan Yu, et al.. (2022). Tetrandrine Prevents Neomycin-Induced Ototoxicity by Promoting Steroid Biosynthesis. Frontiers in Bioengineering and Biotechnology. 10. 876237–876237. 3 indexed citations
8.
Gao, Weitong, Yuqin Wang, Yang Zhou, Xueqian Wang, & Yan Yu. (2022). Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduction and Targeted Therapy. 7(1). 196–196. 690 indexed citations breakdown →
9.
Zhang, Wenjing, et al.. (2021). Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data. Mathematical Biosciences & Engineering. 18(5). 5959–5977. 2 indexed citations
10.
Wang, Juan, Shun Lü, Yehuan Sun, et al.. (2021). OA03.04 Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(1). S3–S3. 1 indexed citations
11.
Ma, Xingkai, Yifang Yuan, Menglin Li, et al.. (2021). Long noncoding RNA ANCR promotes migration, invasion, EMT progress and stemness of nasopharyngeal carcinoma cells via the miR-4731-5p/NMT1 axis. Pathology - Research and Practice. 224. 153540–153540. 6 indexed citations
12.
Xu, Shanqi, Shoubo Cao, Jianxiong Geng, et al.. (2020). High prognostic nutritional index (PNI) as a positive prognostic indicator for non‐small cell lung cancer patients with bone metastasis. The Clinical Respiratory Journal. 15(2). 225–231. 27 indexed citations
13.
14.
Wang, Xin, et al.. (2020). FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma. International Journal of Clinical Oncology. 25(9). 1612–1623. 20 indexed citations
15.
Wu, Rui-Yan, Pengfei Kong, Liang-Ping Xia, et al.. (2019). Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma. Clinical Cancer Research. 25(14). 4530–4541. 80 indexed citations
16.
Liu, Cheng, Yan Yu, Jianxiong Geng, et al.. (2019). TBL1XR1 is involved in c-Met-mediated tumorigenesis of human nonsmall cell lung cancer. Cancer Gene Therapy. 27(3-4). 136–146. 20 indexed citations
17.
Yu, Yan, Bing Hu, Jianxin Bao, et al.. (2018). Otoprotective Effects of Stephania tetrandra S. Moore Herb Isolate against Acoustic Trauma. Journal of the Association for Research in Otolaryngology. 19(6). 653–668. 10 indexed citations
18.
Sun, Ting, Lin Jiao, Yangxia Wang, Yan Yu, & Liang Ming. (2018). SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells. Cell Death and Disease. 9(2). 136–136. 202 indexed citations
19.
He, Qiu-ming, Lei Tan, Rui-Yan Wu, et al.. (2017). Overexpression of PTK6 predicts poor prognosis in bladder cancer patients. Journal of Cancer. 8(17). 3464–3473. 18 indexed citations
20.
Shi, Jin, Yi Deng, Junwei Hao, et al.. (2014). NK Cell Phenotypic Modulation in Lung Cancer Environment. PLoS ONE. 9(10). e109976–e109976. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renea A. Taylor Breakdown of academic impact, for papers by Jian‐An Huang Breakdown of academic impact, for papers by Hiromitsu Mimata Breakdown of academic impact, for papers by Fei Wu Breakdown of academic impact, for papers by Wenjie Zhu Breakdown of academic impact, for papers by Josefa Castillo Breakdown of academic impact, for papers by Soumitro Pal Breakdown of academic impact, for papers by Wei-Chao Chang Breakdown of academic impact, for papers by Federica Papaccio
Rankless by CCL
2026